Comparative analysis of the phosphate-binding effects of sucroferric oxyhydroxide, ferric citrate, and lanthanum carbonate

Table 3 Phosphate change rates compared to patient baseline

FC	Estimate %	Standard Error	p	SF	Estimate %	Standard Error	p	LC	Estimate %	Standard Error	p
Total vs BaseLine	−1.10	1.86	0.56	Total vs BaseLine	−3.33	1.48	0.03*	Total vs BaseLine	−5.36	1.76	0.00*
1	3.16	2.78	0.26	1	1.78	2.43	0.46	1	−0.30	2.46	0.90*
2	1.60	2.78	0.57	2	3.78	2.43	0.12	2	−5.63	2.46	0.02*
3	−1.17	2.78	0.67	3	2.50	2.43	0.30	3	−7.37	2.46	0.00
4	1.18	2.78	0.67	4	2.58	2.43	0.29	4	−4.27	2.46	0.08*
5	−2.89	2.78	0.30	5	2.25	2.43	0.35	5	−6.85	2.46	0.01*
6	−4.08	2.78	0.14	6	5.50	2.43	0.02*	6	−6.92	2.46	0.01*
7	−5.21	2.78	0.06	7	5.61	2.43	0.02*	7	−5.39	2.46	0.03
8	−0.48	2.78	0.86	8	1.10	2.43	0.65	8	−4.80	2.46	0.05
9	−2.36	2.78	0.40	9	1.98	2.43	0.41	9	−3.24	2.46	0.19*
10	−3.12	2.78	0.26	10	−1.11	2.43	0.65	10	−8.79	2.46	0.00*
11	−4.59	2.78	0.10	11	−6.89	2.43	0.00*	11	−6.30	2.46	0.01*
12	−6.69	2.78	0.02*	12	−7.04	2.43	0.00*	12	−5.12	2.46	0.04*
13	−1.26	2.78	0.65	13	−9.88	2.43	<.0001*	13	−7.31	2.46	0.00*
14	−3.11	2.78	0.26	14	−12.61	2.43	<.0001*	14	−12.02	2.46	<.0001*
15	−0.95	2.78	0.73	15	−10.24	2.43	<.0001*	15	−9.00	2.46	0.00*
16	−1.11	2.78	0.69	16	−11.48	2.43	<.0001*	16	−5.68	2.46	0.02*
17	0.37	2.78	0.90	17	−7.65	2.43	0.00*	17	−5.56	2.46	0.02
18	−1.91	2.78	0.49	18	−7.61	2.43	0.00*	18	−4.04	2.46	0.10*
19	−1.06	2.78	0.70	19	−10.30	2.43	<.0001*	19	−6.23	2.46	0.01
20	0.63	2.78	0.82	20	−10.35	2.43	<.0001*	20	−4.79	2.46	0.05
21	2.81	2.78	0.31	21	−11.33	2.43	<.0001*	21	−4.35	2.46	0.08

ISSN: 2059-1381